XCSport体育

<form id='2bEbk'></form>

<bdo id='gGWwK'><sup id='6JpXv'><div id='xEDHt'><bdo id='VoHrh'></bdo></div></sup></bdo>

About Henlius

Company Profile

Corporate Culture

Honor

XCSport体育:Board of Directors

XCSport体育:Management Team

Advisory Committee
Product

Marketed Products

XCSport体育:Products in R&D

XCSport体育:Clinical Trial
Science & Technology

R&D Result

XCSport体育:Innovation Centre

XCSport体育:Technology Platform

XCSport体育:Quality Management

XCSport体育:Manufacturing

Collaborations
Investor Relations

Information Disclosure

Corporate Governance

Financial Reports

XCSport体育:Stock Info

IR Calendar

Investor Presentation

Analyst Coverage

Contact Information
Media

XCSport体育:Press Release

Multi-media

Media Reports

XCSport体育:Media Enquiry
Careers

Talent Philosophy

Staff Life

Training and Development

Job Opportunities
Contact Us

Contact Information

Customer Message

Privacy

Legal Statement

Compliance

EN

简体
EN
繁體

Home

XCSport体育:About Henlius

Company Profile
XCSport体育:Corporate Culture
Honor
XCSport体育:Board of Directors
Management Team
Advisory Committee

Product

Marketed Products
XCSport体育:Products in R&D
Clinical Trial

XCSport体育:Science & Technology

R&D Result
XCSport体育:Innovation Centre
XCSport体育:Technology Platform
XCSport体育:Quality Management
Manufacturing
Collaborations

XCSport体育:Investor Relations

Information Disclosure
Listing Documents Announcement & Circulars
Corporate Governance
Financial Reports
Stock Info
XCSport体育:IR Calendar
Investor Presentation
Analyst Coverage
Contact Information

Media

Press Release
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
XCSport体育:Multi-media
Company Event Popular Science
Media Reports
XCSport体育:Media Enquiry

Careers

Talent Philosophy
Staff Life
Training and Development
Job Opportunities

Contact Us

XCSport体育:Contact Information
XCSport体育:Customer Message
Privacy
XCSport体育:Legal Statement
XCSport体育:Compliance

Be the most trusted biotech company

Press Release
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
XCSport体育:Multi-media
Company XCSport体育:Popular Science Highlights
Download
XCSport体育:Media Reports
Media Enquiry

2021 Q3 Milestone
Henlius half-year (H1) 2021 results
1st Anniversary of 汉曲优® China Approval
2021 Q2 Milestone
2021 Q1 Milestone
2020 Q4 Milestone
2020 Q3 Milestone
Songjiang Manufacturing Facility (Second Plant) Phase 1 Project Milestone
HLX02（汉曲优®, Trastuzumab）Commercial Launch Conference

1
2
3

About Henlius: XCSport体育:Company Profile; XCSport体育:Corporate Culture; Honor; XCSport体育:Board of Directors; Management Team; Advisory Board

Product: Marketed Products; XCSport体育:Products in R&D; XCSport体育:Clinical Trial

XCSport体育:Science & Technology: XCSport体育:R&D Result; XCSport体育:Innovation Centre; Technology Platform; Quality Management; Manufacturing; Collaborations

XCSport体育:Investor Relations: Information Disclosure; XCSport体育:Corporate Governance; Financial Reports; XCSport体育:Stock Info; XCSport体育:IR Calendar; XCSport体育:Investor Presentation; Analyst Coverage; XCSport体育:Contact Information

Media: Press Release; XCSport体育:Multi-media; Media Reports; XCSport体育:Media Enquiry

Careers: XCSport体育:Talent Philosophy; XCSport体育:Staff Life; XCSport体育:Training and Development

XCSport体育:Contact Us: Contact Information; XCSport体育:Customer Message; Privacy; Legal Statement; XCSport体育:Compliance; Adverse Drug Event Reporting

Copyright © 2019 Shanghai Henlius Biotech, Inc. All rights reserved.

Internet Drug Information Service Certification Number: (Shanghai) non-commercial- 2024-0127

Linkedin

WeChat